Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11678984 | 0.77 | — | — | |
| Bromide SCHEMBL11132876 | 0.67 | KDM4E (0.39) | KDM4EALDH1A1HPGDMEN1MAPT | |
| SCHEMBL27521711 | 0.64 | KDM4E (0.41) | KDM4EALDH1A1HPGDMEN1MAPT | |
| SCHEMBL3379071 | 0.64 | KDM4E (0.41) | KDM4EALDH1A1HPGDMEN1MAPT | |
| SCHEMBL23430419 | 0.64 | ALDH1A1 (0.37) | KDM4EALDH1A1HPGDMEN1MAPT | |
| SCHEMBL6850234 | 0.64 | — | — | |
| SCHEMBL28874686 | 0.63 | KDM4E (0.40) | KDM4EALDH1A1HPGDMEN1MAPT | |
| SCHEMBL28212613 | 0.63 | ALDH1A1 (0.43) | KDM4EALDH1A1HPGDMEN1MAPT | |
| SCHEMBL870972 | 0.62 | — | — | |
| SCHEMBL3457997 | 0.61 | KDM4E (0.38) | KDM4EALDH1A1HPGDMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110612119-A | Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents | 西雅图儿童医院（DBA西雅图儿童研究所） | 2019-12-24 | — | — | CN | claimed |
| US-20230022263-A1 | N-TYPE DOPANTS FOR PHOTOACTIVE REGIONS OF ORGANIC PHOTOVOLTAICS | UNIV KING ABDULLAH SCI & TECH (SA) | 2023-01-26 | — | — | US | disclosed |
| US-10858337-B2 | Method for preparing 1,1′-ethylene-2,2′-bipyridinium dichloride | NANJING REDSUN BIOCHEMISTRY CO., LTD. (CN) | 2020-12-08 | — | — | US | disclosed |
| CN-110612119-A | Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents | 西雅图儿童医院（DBA西雅图儿童研究所） | 2019-12-24 | — | — | CN | disclosed |
| EP-1103842-B1 | Electrochromic device | BAYER INNOVATION GMBH (DE) | 2009-07-22 | — | — | EP | disclosed |
| US-4263040-A | Phenoxyphenoxy unsaturated derivatives and herbicidal composition | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1981-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10858337-B2 | Method for preparing 1,1′-ethylene-2,2′-bipyridinium dichloride | DDT, BROX, DBH | KDM4E 4406/4885ALDH1A1 387/4885HPGD 1277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.